The Korean Journal of Medicine

  • 제83권2호
  • /
  • Pages.263-267
  • /
  • 2012
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

CD5- 소포림프종의 CD5+ 광범위큰B세포림프종으로 전환된 1예

Transformation of CD5-Negative Follicular Lymphoma into CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report

  • 김형국 (을지대학교 의과대학 을지대학병원 혈액종양내과) ;
  • 조인성 (을지대학교 의과대학 을지대학병원 혈액종양내과) ;
  • 이혜경 (을지대학교 의과대학 을지대학병원 병리과) ;
  • 최용훈 (을지대학교 의과대학 을지대학병원 혈액종양내과) ;
  • 조성민 (을지대학교 의과대학 을지대학병원 혈액종양내과) ;
  • 문현진 (을지대학교 의과대학 을지대학병원 혈액종양내과) ;
  • 이진아 (을지대학교 의과대학 을지대학병원 혈액종양내과)
  • Kim, Hyeong-Kug (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) ;
  • Cho, In-Sung (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) ;
  • Lee, Hye-Kyung (Department of Pathology, Eulji University Hospital, Eulji University School of Medicine) ;
  • Choi, Yong-Hun (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) ;
  • Cho, Seong-Min (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) ;
  • Moon, Hyun-Jin (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine) ;
  • Lee, Jin-A (Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine)
  • 발행 : 2012.08.01
⟨ 이전 논문 다음 논문 ⟩

초록

이차적인 CD5 양성 광범위큰B세포림프종에서의 적절한 임상적 치료에 대한 좀 더 많은 논의가 필요할 것으로 생각된다. 본 증례는 장기간의 치료 기간 동안 잦은 재발을 보이는 소포림프종에서 좀 더 나쁜 예후를 보이는 CD5 양성 광범위큰B세포림프종으로 전환된 환자에서 기존에 알려진 치료와는 다른 구제요법을 통해 성공적인 치료성적을 보였고 치료 후 완전 관해를 보였다는 점에서 의의가 있음을 보고 하는 바이다.

Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of aggressive lymphomas. Approximately 10% of DLBCL cases express CD5 as a surface antigen. CD5-positive DLBCL can occur as the de novo or secondary type. De novo CD5-positive DLBCL arises without previous lymphoproliferative disease, and secondary CD5-positive DLBCL may or may not manifest as Richter syndrome. The transformation of follicular lymphoma (FL) into DLBCL occurs in approximately one-third of all cases. The transformation of CD5-negative low-grade B-cell lymphoma to CD5-positive DLBCL is extremely rare. We report the clinical features of a rare case that presented with a transformation from CD5-negative FL to CD5-positive DLBL over 11 years. This is the second such case published in the English literature.

키워드

참고문헌

  1. Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol 2011;45:254-260. https://doi.org/10.4132/KoreanJPathol.2011.45.3.254
  2. Lee Y, Kyung SY, Choi SJ, et al. Two cases of interstitial pneumonitis caused by rituximab therapy. Korean J Intern Med 2006;21:183-186. https://doi.org/10.3904/kjim.2006.21.3.183
  3. Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res Clin Haematol 2011;24:147-163. https://doi.org/10.1016/j.beha.2011.02.006
  4. Maeshima AM, Taniguchi H, Nomoto J, et al. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome). Am J Clin Pathol 2009;131:339-346. https://doi.org/10.1309/AJCP58FETFGLCKKW
  5. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol 1999;105:1133-1139. https://doi.org/10.1046/j.1365-2141.1999.01513.x
  6. Sekiguchi Y, Imai H, Wakabayashi M, et al. CD5-positive follicular lymphoma: a case report and literature review. Intern Med 2011;50:899-904. https://doi.org/10.2169/internalmedicine.50.4339
  7. Burastero SE, Casali P. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce. Contrib Microbiol Immunol 1989;11:231-262.
  8. Pospisil R, Silverman GJ, Marti GE, Aruffo A, Bowen MA, Mage RG. CD5 is apotential selecting ligand for B-cell surface immunoglobulin: a possible role in maintenance and selective expansion of normal and malignant B cells. Leuk lymphoma 2000;36:353-365. https://doi.org/10.3109/10428190009148857
  9. Williams CD, Harrison CN, Lister TA, et al. High-dose therapy and autologus stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a-case matched study from the European Bone Marrow Transformed follicular lymphoma. Eur J Haemaetol 2000; 65:17-22. https://doi.org/10.1034/j.1600-0609.2000.90114.x
  10. Bernstein SH, Burack WR. The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology Am Soc Hematol Educ Program 2009:532-541.